MedMira Laboratories: The U.S. OTC Decision Harvard Case Solution & Analysis

In December 2005, Vice President of Global Sales and Marketing MedMira Laboratories in Halifax, Nova Scotia, to decide to enter into over-the-counter (OTC) market testing for HIV in the United States, if the company receives approval from the Food and Drug Administration USA . Entrance into the market has the potential to open the doors for OTC sales of other infectious diseases that may develop MedMira tests with current technology. Do not go to the market could result in disapproval of the shareholders and significant missed opportunity. With the exception of China, most of the tests the company were sold to hospitals and laboratories, so the U.S. OTC sales will require the development of new marketing and distribution of knowledge. It would also be very costly for a small company with accumulated losses. If MedMira decides to market, vice president of global sales and marketing need to determine whether to do it alone or with a partner Home Access Health Corporation, a Chicago-based company, which has only FDA approved home test system on the market. There are also a number of ethical issues surrounding at-home test that need to be addressed. "Hide
by Julia Sagebien Source: Richard Ivey School of Business Foundation 14 pages. Publication Date: November 10, 2006. Prod. # 906A24-PDF-ENG

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.